A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention.
Geisen C, Fleck E, Schäfer SMG, Walter C, Braeuninger S, Jensen JS, Sheridan D, Patki K, Armstrong R, Skogen B, Behrens F, Seifried E, Kjeldsen-Kragh J, Kjær M, Köhm M.
Geisen C, et al. Among authors: sheridan d.
Thromb Haemost. 2024 Sep 12. doi: 10.1055/a-2398-9344. Online ahead of print.
Thromb Haemost. 2024.
PMID: 39168139
Free article.